Smoore International Holdings Limited
Smoore International Holdings Limited SMORF Peers
See (SMORF) competitors and their performances in Stock Market.
Peer Comparison Table: Tobacco Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SMORF | $1.25 | +0.00% | 7.6B | 41.67 | $0.03 | +0.64% |
| BTAFF | $45.50 | -2.56% | 106.1B | 26.20 | $1.85 | +6.40% |
| JAPAY | $14.64 | -0.98% | 52.9B | 42.60 | $0.35 | +2.96% |
| JAPAF | $29.13 | -6.03% | 51.7B | 42.22 | $0.69 | +4.28% |
| IMBBF | $39.36 | -1.00% | 32.9B | 9.65 | $4.06 | +5.74% |
| IMBBY | $39.44 | +1.18% | 32.5B | 9.54 | $4.06 | +5.64% |
| SWMAY | $10.57 | +0.00% | 16.1B | 27.82 | $0.38 | N/A |
| PHJMF | $0.05 | +0.00% | 5.8B | 5.00 | $0.01 | +6.86% |
| PHPMF | $869.36 | -0.64% | 1.7B | 15.43 | $56.35 | +6.47% |
| GGNPF | $0.58 | +0.00% | 1.1B | 29.00 | $0.02 | N/A |
Stock Comparison
SMORF vs BTAFF Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, BTAFF has a market cap of 106.1B. Regarding current trading prices, SMORF is priced at $1.25, while BTAFF trades at $45.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas BTAFF's P/E ratio is 26.20. In terms of profitability, SMORF's ROE is +0.07%, compared to BTAFF's ROE of -0.27%. Regarding short-term risk, SMORF is more volatile compared to BTAFF. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs JAPAY Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, JAPAY has a market cap of 52.9B. Regarding current trading prices, SMORF is priced at $1.25, while JAPAY trades at $14.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas JAPAY's P/E ratio is 42.60. In terms of profitability, SMORF's ROE is +0.07%, compared to JAPAY's ROE of +0.08%. Regarding short-term risk, SMORF is more volatile compared to JAPAY. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs JAPAF Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, JAPAF has a market cap of 51.7B. Regarding current trading prices, SMORF is priced at $1.25, while JAPAF trades at $29.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas JAPAF's P/E ratio is 42.22. In terms of profitability, SMORF's ROE is +0.07%, compared to JAPAF's ROE of +0.08%. Regarding short-term risk, SMORF is more volatile compared to JAPAF. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs IMBBF Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, IMBBF has a market cap of 32.9B. Regarding current trading prices, SMORF is priced at $1.25, while IMBBF trades at $39.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas IMBBF's P/E ratio is 9.65. In terms of profitability, SMORF's ROE is +0.07%, compared to IMBBF's ROE of +0.46%. Regarding short-term risk, SMORF is more volatile compared to IMBBF. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs IMBBY Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, IMBBY has a market cap of 32.5B. Regarding current trading prices, SMORF is priced at $1.25, while IMBBY trades at $39.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas IMBBY's P/E ratio is 9.54. In terms of profitability, SMORF's ROE is +0.07%, compared to IMBBY's ROE of +0.53%. Regarding short-term risk, SMORF is more volatile compared to IMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs SWMAY Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, SWMAY has a market cap of 16.1B. Regarding current trading prices, SMORF is priced at $1.25, while SWMAY trades at $10.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas SWMAY's P/E ratio is 27.82. In terms of profitability, SMORF's ROE is +0.07%, compared to SWMAY's ROE of N/A. Regarding short-term risk, SMORF is more volatile compared to SWMAY. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs PHJMF Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, PHJMF has a market cap of 5.8B. Regarding current trading prices, SMORF is priced at $1.25, while PHJMF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas PHJMF's P/E ratio is 5.00. In terms of profitability, SMORF's ROE is +0.07%, compared to PHJMF's ROE of +0.23%. Regarding short-term risk, SMORF is more volatile compared to PHJMF. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs PHPMF Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, PHPMF has a market cap of 1.7B. Regarding current trading prices, SMORF is priced at $1.25, while PHPMF trades at $869.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas PHPMF's P/E ratio is 15.43. In terms of profitability, SMORF's ROE is +0.07%, compared to PHPMF's ROE of +0.46%. Regarding short-term risk, SMORF is more volatile compared to PHPMF. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs GGNPF Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, GGNPF has a market cap of 1.1B. Regarding current trading prices, SMORF is priced at $1.25, while GGNPF trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas GGNPF's P/E ratio is 29.00. In terms of profitability, SMORF's ROE is +0.07%, compared to GGNPF's ROE of +0.01%. Regarding short-term risk, SMORF is more volatile compared to GGNPF. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs GDNGY Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, GDNGY has a market cap of 1B. Regarding current trading prices, SMORF is priced at $1.25, while GDNGY trades at $2.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas GDNGY's P/E ratio is 36.21. In terms of profitability, SMORF's ROE is +0.07%, compared to GDNGY's ROE of +0.01%. Regarding short-term risk, SMORF is more volatile compared to GDNGY. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs STBGY Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, STBGY has a market cap of 1B. Regarding current trading prices, SMORF is priced at $1.25, while STBGY trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas STBGY's P/E ratio is 8.05. In terms of profitability, SMORF's ROE is +0.07%, compared to STBGY's ROE of +0.10%. Regarding short-term risk, SMORF is more volatile compared to STBGY. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs SNDVF Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, SNDVF has a market cap of 1B. Regarding current trading prices, SMORF is priced at $1.25, while SNDVF trades at $13.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas SNDVF's P/E ratio is 8.21. In terms of profitability, SMORF's ROE is +0.07%, compared to SNDVF's ROE of +0.10%. Regarding short-term risk, SMORF is more volatile compared to SNDVF. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs KCIGF Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, KCIGF has a market cap of 828M. Regarding current trading prices, SMORF is priced at $1.25, while KCIGF trades at $300.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas KCIGF's P/E ratio is 8.83. In terms of profitability, SMORF's ROE is +0.07%, compared to KCIGF's ROE of +0.14%. Regarding short-term risk, SMORF is more volatile compared to KCIGF. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs PYYX Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, PYYX has a market cap of 125.5M. Regarding current trading prices, SMORF is priced at $1.25, while PYYX trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas PYYX's P/E ratio is 8.64. In terms of profitability, SMORF's ROE is +0.07%, compared to PYYX's ROE of +0.07%. Regarding short-term risk, SMORF is more volatile compared to PYYX. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs CHUC Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, CHUC has a market cap of 25.3M. Regarding current trading prices, SMORF is priced at $1.25, while CHUC trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas CHUC's P/E ratio is -4.92. In terms of profitability, SMORF's ROE is +0.07%, compared to CHUC's ROE of +4.44%. Regarding short-term risk, SMORF is more volatile compared to CHUC. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs GRAM Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, GRAM has a market cap of 10.9M. Regarding current trading prices, SMORF is priced at $1.25, while GRAM trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas GRAM's P/E ratio is -0.09. In terms of profitability, SMORF's ROE is +0.07%, compared to GRAM's ROE of +2.93%. Regarding short-term risk, SMORF is more volatile compared to GRAM. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs GGII Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, GGII has a market cap of 6.4M. Regarding current trading prices, SMORF is priced at $1.25, while GGII trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas GGII's P/E ratio is N/A. In terms of profitability, SMORF's ROE is +0.07%, compared to GGII's ROE of -0.51%. Regarding short-term risk, SMORF is more volatile compared to GGII. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs VAPR Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, VAPR has a market cap of 4.7M. Regarding current trading prices, SMORF is priced at $1.25, while VAPR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas VAPR's P/E ratio is N/A. In terms of profitability, SMORF's ROE is +0.07%, compared to VAPR's ROE of +0.95%. Regarding short-term risk, SMORF is more volatile compared to VAPR. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs VPRB Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, VPRB has a market cap of 3.7M. Regarding current trading prices, SMORF is priced at $1.25, while VPRB trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas VPRB's P/E ratio is -4.00. In terms of profitability, SMORF's ROE is +0.07%, compared to VPRB's ROE of +0.12%. Regarding short-term risk, SMORF is more volatile compared to VPRB. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs LBRG Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, LBRG has a market cap of 2.7M. Regarding current trading prices, SMORF is priced at $1.25, while LBRG trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas LBRG's P/E ratio is N/A. In terms of profitability, SMORF's ROE is +0.07%, compared to LBRG's ROE of -0.23%. Regarding short-term risk, SMORF is more volatile compared to LBRG. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs CBDW Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, CBDW has a market cap of 1.5M. Regarding current trading prices, SMORF is priced at $1.25, while CBDW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas CBDW's P/E ratio is -0.22. In terms of profitability, SMORF's ROE is +0.07%, compared to CBDW's ROE of +2.07%. Regarding short-term risk, SMORF is less volatile compared to CBDW. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.
SMORF vs WSRRF Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, WSRRF has a market cap of 1.5M. Regarding current trading prices, SMORF is priced at $1.25, while WSRRF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas WSRRF's P/E ratio is -1.26. In terms of profitability, SMORF's ROE is +0.07%, compared to WSRRF's ROE of +1.29%. Regarding short-term risk, SMORF is more volatile compared to WSRRF. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs TOBAF Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, TOBAF has a market cap of 1.5M. Regarding current trading prices, SMORF is priced at $1.25, while TOBAF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas TOBAF's P/E ratio is -0.29. In terms of profitability, SMORF's ROE is +0.07%, compared to TOBAF's ROE of +0.61%. Regarding short-term risk, SMORF is more volatile compared to TOBAF. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs HUMBF Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, HUMBF has a market cap of 521.6K. Regarding current trading prices, SMORF is priced at $1.25, while HUMBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas HUMBF's P/E ratio is -0.04. In terms of profitability, SMORF's ROE is +0.07%, compared to HUMBF's ROE of -1.03%. Regarding short-term risk, SMORF is more volatile compared to HUMBF. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs MEDH Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, MEDH has a market cap of 89.9K. Regarding current trading prices, SMORF is priced at $1.25, while MEDH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas MEDH's P/E ratio is -0.04. In terms of profitability, SMORF's ROE is +0.07%, compared to MEDH's ROE of -0.03%. Regarding short-term risk, SMORF is more volatile compared to MEDH. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs IDLSF Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, IDLSF has a market cap of 80.1K. Regarding current trading prices, SMORF is priced at $1.25, while IDLSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas IDLSF's P/E ratio is N/A. In terms of profitability, SMORF's ROE is +0.07%, compared to IDLSF's ROE of N/A. Regarding short-term risk, SMORF is more volatile compared to IDLSF. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs VPOR Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, VPOR has a market cap of 27.3K. Regarding current trading prices, SMORF is priced at $1.25, while VPOR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas VPOR's P/E ratio is N/A. In terms of profitability, SMORF's ROE is +0.07%, compared to VPOR's ROE of +0.00%. Regarding short-term risk, SMORF is more volatile compared to VPOR. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.
SMORF vs ASHI Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, ASHI has a market cap of 9.2K. Regarding current trading prices, SMORF is priced at $1.25, while ASHI trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas ASHI's P/E ratio is -0.39. In terms of profitability, SMORF's ROE is +0.07%, compared to ASHI's ROE of +0.12%. Regarding short-term risk, SMORF is less volatile compared to ASHI. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.
SMORF vs SWMAF Comparison
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 7.6B. In comparison, SWMAF has a market cap of 0. Regarding current trading prices, SMORF is priced at $1.25, while SWMAF trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 41.67, whereas SWMAF's P/E ratio is N/A. In terms of profitability, SMORF's ROE is +0.07%, compared to SWMAF's ROE of N/A. Regarding short-term risk, SMORF is more volatile compared to SWMAF. This indicates potentially higher risk in terms of short-term price fluctuations for SMORF.